The Legal, Regulatory and Compliance Forum on Dietary Supplements
Event | 06.26.13 - 06.27.13, 12:00 AM UTC - 12:00 AM UTC
Recent changes in Congress and at FDA have presented the dietary supplements industry with a whole new set of challenges. The imminent departure of long –time industry champion Senator Tom Harkin and the push for more stringent AER requirements in view of the caffeine/energy drink controversy in Congress, not to mention possible FDA rule making extending certain provisions of FSMA to dietary supplements have caused supplement manufacturers great concern. However, signs of hope are on the horizon. FDA has agreed to revise a controversial draft guidance for New Dietary Ingredients -- a decision which industry groups have applauded and believe to signal the beginning of an open dialogue with the agency.
To help you make sense of these developments and their potential impact on existing legal and regulatory structures affecting products intended to supplement the diet, American Conference Institute has developed The Legal, Regulatory and Compliance Forum on Dietary Supplements. A distinguished faculty of over two dozen leading legal and regulatory Dietary Supplement experts --- including representatives from the FDA, FTC, NAD, CRN and NPA --- will address the intricacies and implications of these new developments as well as existing challenges affecting such core dietary supplement functions as FDA and regulatory affairs; advertising and promotion; trademarks, trade names and line extensions; and studies
For more information, please visit these areas: Litigation and Trial, Product Risk Management
Insights
Event | 02.20.25
Has the Buss Stopped? Recoupment Today
Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.
Event | 02.18.25 - 02.20.25
Event | 12.05.24
Event | 12.05.24
